DE292149C - - Google Patents

Info

Publication number
DE292149C
DE292149C DENDAT292149D DE292149DA DE292149C DE 292149 C DE292149 C DE 292149C DE NDAT292149 D DENDAT292149 D DE NDAT292149D DE 292149D A DE292149D A DE 292149DA DE 292149 C DE292149 C DE 292149C
Authority
DE
Germany
Prior art keywords
ether
alcohol
water
solution
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT292149D
Other languages
German (de)
Publication of DE292149C publication Critical patent/DE292149C/de
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Description

KAISERLICHESIMPERIAL

PATENTAMT.PATENT OFFICE.

Es wurde gefunden, daß man feste, haltbare Präparate von Alkalisalzen des 4It has been found that solid, durable preparations of alkali salts of the 4th

3 · 31-diaminoarsenobenzols gewinnt, indem man Lösungen dieser Salze mit mehrwertigen Al· koholen, wie Mannit, Dulcit, Erythrit, Arabit usw., versetzt und sodann aus solcher Lösung durch Zugabe von indifferenten Mitteln, wie Alkohol und Äther, die neuen Präparate fällt und abtrennt. In denselben liegen nicht neue chemische Verbindungen, sondern innige Gemenge der genannten Alkalisalze mit den mehrwertigen Alkoholen vor. Die neuen Präparate sind zitronengelbe, in Wasser leicht und mit alkalischer Reaktion lösliche, in Alkohol und Äther schwer lösliche Pulver. Im Vergleich zu den reinen Alkalisalzen des Diaminodioxyarsenobenzols sind die neuen Präparate haltbar, namentlich dann, wenn sie unter Luftabschluß aufbewahrt werden.3 · 3 1 -diaminoarsenobenzene is obtained by adding polyhydric alcohols to solutions of these salts, such as mannitol, dulcitol, erythritol, arabitol, etc., and then from such a solution by adding inert agents such as alcohol and ether, the new preparations falls and separates. They do not contain new chemical compounds, but intimate mixtures of the alkali salts mentioned with the polyhydric alcohols. The new preparations are lemon-yellow powders that are easily soluble in water and with an alkaline reaction, and poorly soluble in alcohol and ether. Compared to the pure alkali salts of diaminodioxyarsenobenzene, the new preparations are stable, especially if they are kept in the absence of air.

Zur Darstellung der neuen Präparate verfährt man wie folgt:To display the new preparations, proceed as follows:

Beispiele.Examples.

i. 47,5 g 4 · 4^DiOXy-S · 31-diaminoarsenobenzolchlorhydrat werden in 200 ecm Wasser gelöst und mit der theoretischen Menge zehnfach normaler Natronlauge versetzt (= 40 ecm). Zu dieser Lösung fügt man 17,2 g Mannit, gelöst in 75 ecm Wasser.i. 47.5 g of 4 · 4 ^ DiOXy-S · 3 1 -diaminoarsenobenzene chlorohydrate are dissolved in 200 ecm of water and mixed with the theoretical amount of ten times normal sodium hydroxide solution (= 40 ecm). 17.2 g of mannitol, dissolved in 75 ecm of water, are added to this solution.

Mischt man die so hergestellte Lösung mit 4 1 absolutem Alkohol und 4 1 Äther, so fällt ein gelbes Pulver aus, das in Wasser leicht, in Alkohol, Äther, Aceton schwer löslich ist.If the solution prepared in this way is mixed with 4 liters of absolute alcohol and 4 liters of ether, it precipitates a yellow powder, which is easily soluble in water but sparingly soluble in alcohol, ether, acetone.

2- 47»5 S 4' 41OiOXy-S · 31-diaminoarsenobenzolchlorhydrat werden in 240 ecm Wasser gelöst, mit 40 ecm zehnfach normaler Na O H versetzt und zu der alkalischen Lösung 12,2 g Erythrit in 40 g Wasser zugegeben. Beim Einfließenlassen der Lösung in Alkohol oder Äther, oder Älkohol-Äthergemisch wird ein gelbes Pulver gefällt, welches sich leicht in Wasser, schwer in Alkohol, Äther, Benzol, Aceton usw. löst. 2-47 »5 S 4 '4-1 OiOXy S · 3 1 -diaminoarsenobenzolchlorhydrat be dissolved in 240 cc of water, mixed with 40 cc of ten times normal Na OH and 12.2 g of erythritol in 40 g of water was added to the alkaline solution. When the solution is poured into alcohol or ether, or a mixture of alcohol and ether, a yellow powder is precipitated which dissolves easily in water, difficult in alcohol, ether, benzene, acetone, etc.

Claims (1)

Patent-Anspruch:Patent claim: Verfahren zur Darstellung haltbarer Präparate der Alkalisalze des 3 · 31-Diamino-4 · 4x-dioxyarsenobenzols, darin bestehend, daß man Lösungen, welche diese Salze und mehrwertige Alkohole enthalten, mit Alkohol und Äther mischt und die entstehende Fällung abtrennt.Process for the preparation of durable preparations of the alkali salts of 3 · 3 1 -diamino-4 · 4 x -dioxyarsenobenzene, consisting in that solutions containing these salts and polyhydric alcohols are mixed with alcohol and ether and the resulting precipitate is separated off.
DENDAT292149D Active DE292149C (en)

Publications (1)

Publication Number Publication Date
DE292149C true DE292149C (en)

Family

ID=546954

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT292149D Active DE292149C (en)

Country Status (1)

Country Link
DE (1) DE292149C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011179A1 (en) * 1990-01-24 1991-08-08 National Research Development Corporation Aerosol carriers
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
US5935897A (en) * 1995-09-12 1999-08-10 Basf Aktiengesellschaft Monomodal and polymodal catalyst supports and catalysts having narrow pore size distributions and their production
US7867937B2 (en) 2006-12-15 2011-01-11 Exxonmobil Research And Engineering Company Drying device for producing small quantities of controlled particle size catalysts which are appropriate for use in fluidized bed operations such as fluid catalytic cracking

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011179A1 (en) * 1990-01-24 1991-08-08 National Research Development Corporation Aerosol carriers
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
US5935897A (en) * 1995-09-12 1999-08-10 Basf Aktiengesellschaft Monomodal and polymodal catalyst supports and catalysts having narrow pore size distributions and their production
US7867937B2 (en) 2006-12-15 2011-01-11 Exxonmobil Research And Engineering Company Drying device for producing small quantities of controlled particle size catalysts which are appropriate for use in fluidized bed operations such as fluid catalytic cracking

Similar Documents

Publication Publication Date Title
EP0177870B1 (en) Stabilized injection solutions of piroxicam
DE60126433T2 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
DE292149C (en)
EP0217270B1 (en) Dust-free alginate impression materials
DE3619665A1 (en) QUATERIAL AMMONIUM SALTS OF FUROSEMID, MEDICINAL PRODUCTS CONTAINING THEM AND METHOD FOR THE PRODUCTION THEREOF
Koźlicka-Gajdińska et al. A case of fatal intoxication with sodium azide
US2824042A (en) Composition for preparation of burow's solution
EP0030681B1 (en) Directly injectable aqueous solutions of the alkali salts of canrenoic acid and of furosemide, and process for their production
DE697855C (en) Sugar-lowering hormone of the pancreas
DE212070C (en)
DE1695158A1 (en) Process for the manufacture of antibiotics
DE255030C (en)
DE2156056C3 (en) 3-tf ', 2'-diphenylethyl) -5- (2piperidino-ethyl) -1,2,4-oxadiazole-4-hydroxybenzoylbenzoate- (2), its preparation and preparations containing these compounds
DE91718C (en)
DE667845C (en) Process for the preparation of symmetrical dioxalkylated aminoarsenobenzenes
DE78889C (en) Process for the preparation of tribromophenol bismuth
DE250884C (en)
DE454701C (en) Process for the preparation of derivatives of arsenostibiobenzene which are symmetrically disubstituted in the 3,4-position
DE825407C (en) Process for the production of soluble gold compounds
DE268220C (en)
DE2140100C3 (en) Concentrated supplementary solution for the regeneration of depleted alkaline aqueous copper (II) ions, formaldehyde and a complexing agent for copper (H> ions containing baths for electroless copper plating and their use
DE695095C (en) Process for the representation of substances influencing blood pressure from urine
DE2404931A1 (en) PSYCHOTONIC
DE1668611C (en) 3- (beta-diethylaminoethoxy) -16-oxo-delta high 1,3,5 (10) -estratriene, 3- (beta-diethylaminoethoxy) -17-oxo-delta high 1,3,5 (10) -lumi- estatriums and their chlorohydrates and processes for their preparation
DE2540523A1 (en) DERIVATIVES OF AMOXYCILLIN, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE DERIVATIVES